Infective endocarditis risk in patients with bicuspid aortic valve: Systematic review and meta-analysis
IJC Heart & Vasculature · 2023-08 · 47 · 101249
DOI: 10.1016/j.ijcha.2023.101249 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift IJC Heart & Vasculature, 2023-08. Verfasst von Sara Couto Pereira und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Hospital Universitário de Santa Maria - CHULN, Portugal. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundação para a Ciência e a Tecnologia.
Abstract (Originalsprache)
Background
Antibiotic prophylaxis in bicuspid aortic valve patients is currently a matter of debate. Although it is no longer recommended by international guidelines, some studies indicate a high risk of infective endocarditis. We aim to evaluate the risk of native valve infective endocarditis in bicuspid aortic valve patients and compare to individuals with tricuspid aortic valve.
Methods
Study search of longitudinal studies regarding infective endocarditis incidence in bicuspid aortic valve patients (compared with tricuspid aortic valve/overall population) was conducted through OVID in the following electronic databases: MEDLINE, CENTRAL, EMBASE; from inception until October 2020. The outcomes of interest were the incidence rate and relative risk of infective endocarditis. The relative risk and incidence rate (number of cases for each 10 000 persons-year) with their 95 % confidence intervals (95 %CI) were estimated using a random effects model meta-analysis. The study protocol was registered at PROSPERO CRD42020218639.
Results
Eight cohort studies were selected, with a total of 5351 bicuspid aortic valve patients. During follow up, 184 bicuspid aortic valve patients presented infective endocarditis, with an incidence rate of 48.13 per 10,000 patients-year (95 %CI 22.24-74.02), and a 12-fold (RR: 12.03, 95 %CI 5.45-26.54) increased risk compared with general population, after adjusted estimates.
Conclusions
This systematic review and meta-analysis suggests that bicuspid aortic valve patients have a significant high risk of native valve infective endocarditis. Large prospective high-quality studies are required to estimate more accurately the incidence of infective endocarditis, the relative risk and the potential benefit of antibiotic prophylaxis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiology Department, Hospital Universitário de Santa Maria - CHULN, Portugal.
- Centro Cardiovascular da Universidade de Lisboa - CCUL (CCUL@RISE), CAML, Faculdade de Medicina, Universidade de Lisboa, Portugal.
- Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, Portugal.
Förderung
- Fundação para a Ciência e a Tecnologia
Zitieren
APA
Pereira, S. C., Abrantes, A. L., António, P. S., Morais, P., Sousa, C., David, C., Pinto, F. J., Almeida, A. G., & Caldeira, D. (2023). Infective endocarditis risk in patients with bicuspid aortic valve: Systematic review and meta-analysis. IJC Heart & Vasculature, 47, 101249. https://doi.org/10.1016/j.ijcha.2023.101249
Vancouver
Pereira SC, Abrantes AL, António PS, Morais P, Sousa C, David C, et al. Infective endocarditis risk in patients with bicuspid aortic valve: Systematic review and meta-analysis. IJC Heart & Vasculature. 2023;47:101249. doi:10.1016/j.ijcha.2023.101249
BibTeX
@article{Pereira2023,
author = {Pereira, Sara Couto and Abrantes, Ana Lobato and António, Pedro Silverio and Morais, Pedro and Sousa, Catarina and David, Cláudio and Pinto, Fausto J and Almeida, Ana G and Caldeira, Daniel},
title = {Infective endocarditis risk in patients with bicuspid aortic valve: Systematic review and meta-analysis},
journal = {IJC Heart & Vasculature},
year = {2023},
volume = {47},
pages = {101249},
doi = {10.1016/j.ijcha.2023.101249}
}
EUVIMED